首页/数据集/Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients: a randomized controlled phase 2 trial

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients: a randomized controlled phase 2 trial

NCATS Open Data2022-03-11 更新2026-08-08 收录

新冠疫苗异源加强免疫

疫苗免疫原性

数据链接：

https://doi.org/10.1101/2022.03.08.22272062 数据链接链接失效反馈

官方服务：

资源简介：

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients: a randomized controlled phase 2 trial

应用场景：

创建时间：

2022-03-10

疫苗免疫原性

中和抗体动态监测

Female BALB/c mice (4–6 weeks old) were i.p. inoculated with three EV71 FCP-As (V1, V2, and V3) containing 200 U antigen. The sera were isolated and tested at 7, 14, 21, 28, 56 and 84 d post-inoculati

NIAID Data Ecosystem100

Table S1 - Reducing the Activity and Secretion of Microbial Antioxidants Enhances the Immunogenicity of BCG

疫苗免疫原性

微生物遗传工程

Tools for genetic manipulations and bacterial strains (0.05 MB DOC)

NIAID Data Ecosystem20

MOESM1 of Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02A

疫苗免疫原性

抗体滴度分析

Additional file 1. AMA1 IgG subclass titers, total IgG titers, and cytophilic ratios for AMA1 vaccine and control groups.

Figshare2019-01-19 更新10

Immunogenicity of homologous versus heterologous B mHA WIVs in mice

疫苗免疫原性

甲型流感病毒研究

A head-to-head comparision of the immuogenicity of the homologous verus heterologous B mHA WIV in mice. The immunization groups include those in B mHA-immuno-01 and B mHA-immuno-02 studies using AddaV

NIAID Data Ecosystem30

Dataset from Phase IV Open Study to Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Live Attenuated Measles-Mumps-Rubella (MMR) Vaccine When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

疫苗免疫原性

疫苗安全性监测

To evaluate the safety and immunogenicity of GSK Biologicals' live attenuated MMR vaccine (Priorix) in a local population in Singapore. The vaccine was administered as a single dose to healthy childre

NIAID Data Ecosystem10

Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients: a randomized controlled phase 2 trial

资源简介：

相关数据集